IGF1SDS vs ERKNet Leila

367 / 5 000 Résultats de traduction IGF1SDS_score calculates the Z score of IGF 1 according to the kit used, gender, age group (given either in age group, age or year of birth) and IGF-A level measured in ng /ml or nmol/l. The Z score or SD score for Standard deviation score and gives the admissible limit values and the conversion of the IGF-1 value in the unit not provided.

The European Rare Kidney Disease Reference Network (ERKNet), in collaboration with Leila, presents a practical tool designed to support your daily clinical practice. ERKNet experts have developed clinical practice recommendations for a number of rare kidney disease conditions and complemented them with diagnostic pathways and treatment protocols—all easily accessible in one place. With its user-friendly interface, the app also offers helpful tools such as glossaries, kidney function test calculators, and step-by-step decision pathways to guide your clinical decisions. The ERKNet/Leila App is continuously updated with new guidelines and insights, ensuring you always have the most current information at your fingertips. I ERKNet/Leila is your resource for navigating the complexities of rare kidney disease management. Download now and join us in harmonizing patient care! Note: ERKNet/Leila is not a medical device. The ERKNet/Leila app is intended for doctors and medical staff. To be able to use the app, you must confirm this when you start the app for the first time. The information provided by the app is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. All content is created and checked by medical specialists, doctors and an experienced editorial team. Nevertheless, we cannot assume any liability for third-party content, such as the content of scores, epidemiological content, regulatory information, specialist information that is included in the glossaries as a knowledge base, and for the guidelines and their content. ERKNet is funded by the European Union within the framework of the EU4Health Programme 2021-2027. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.